2022 Enduring Materials
Accreditation
For Physicians:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Pennsylvania Medical Society and Pennsylvania Allergy and Asthma Association. The Pennsylvania Medical Society is accredited by the ACCME to provide continuing medical education for physicians.
The Pennsylvania Medical Society designates these enduring materials for a maximum of 11.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and all others who have the ability to control the content of continuing medical education activities sponsored by Pennsylvania Medical Society are expected to disclose to the audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).
For Physicians:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Pennsylvania Medical Society and Pennsylvania Allergy and Asthma Association. The Pennsylvania Medical Society is accredited by the ACCME to provide continuing medical education for physicians.
The Pennsylvania Medical Society designates these enduring materials for a maximum of 11.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and all others who have the ability to control the content of continuing medical education activities sponsored by Pennsylvania Medical Society are expected to disclose to the audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).
Recordings & Speaker Information
COVID-19 in Primary Immune Deficiencies
|
The Hyper IgE Syndromes
|
Alexandra Freeman
Dr. Alexandra Freeman is a pediatric infectious diseases physician at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health who focuses on the diagnosis and management of primary immunodeficiencies. Dr. Freeman received her medical training at Georgetown University Medical School, completed her pediatric residency training at Yale New Haven Children’s hospital and her pediatric infectious diseases fellowship at Northwestern’s program in Chicago. She then joined NIH as an attending physician, briefly focusing on pediatric HIV and then changing her focus to primary immunodeficiency. Her primary focus is Hyper IgE syndromes, and she has been involved in the initial genetic diagnosis of multiple of these syndromes, and is recognized worldwide as an expert in the management of these patients due to her large cohorts of patients followed at NIAID. She also directs the primary immunodeficiency clinic at NIAID in which she educates the allergy/immunology fellows in the diagnosis and management of individuals with complex primary immunodeficiencies. Dr. Freeman has over 180 peer-reviewed journal articles, multiple book chapters and reviews, and has been a speaker in many national and international conferences on the topic of primary immunodeficiencies.
Dr. Alexandra Freeman is a pediatric infectious diseases physician at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health who focuses on the diagnosis and management of primary immunodeficiencies. Dr. Freeman received her medical training at Georgetown University Medical School, completed her pediatric residency training at Yale New Haven Children’s hospital and her pediatric infectious diseases fellowship at Northwestern’s program in Chicago. She then joined NIH as an attending physician, briefly focusing on pediatric HIV and then changing her focus to primary immunodeficiency. Her primary focus is Hyper IgE syndromes, and she has been involved in the initial genetic diagnosis of multiple of these syndromes, and is recognized worldwide as an expert in the management of these patients due to her large cohorts of patients followed at NIAID. She also directs the primary immunodeficiency clinic at NIAID in which she educates the allergy/immunology fellows in the diagnosis and management of individuals with complex primary immunodeficiencies. Dr. Freeman has over 180 peer-reviewed journal articles, multiple book chapters and reviews, and has been a speaker in many national and international conferences on the topic of primary immunodeficiencies.
2020 Updates to Asthma Management Guidelines: SMART Dosing in Asthma
|
Disparities in Asthma
|
Torie Grant, MD, MHS
Torie Grant is a graduate of the University of Maryland School of Medicine. She went on to complete a combined residency in Internal Medicine/Pediatrics at the University of Maryland Medical Center. From there, she moved to the Johns Hopkins University School of Medicine where she completed her fellowship in Pediatric Allergy and Immunology and earned a master’s degree in epidemiology from the Johns Hopkins Bloomberg School of Public Health. Dr. Grant is an Assistant Professor of Medicine and Pediatrics at the Johns Hopkins University School of Medicine, and her primary research interest is in urban exposures and lung function growth.
Torie Grant is a graduate of the University of Maryland School of Medicine. She went on to complete a combined residency in Internal Medicine/Pediatrics at the University of Maryland Medical Center. From there, she moved to the Johns Hopkins University School of Medicine where she completed her fellowship in Pediatric Allergy and Immunology and earned a master’s degree in epidemiology from the Johns Hopkins Bloomberg School of Public Health. Dr. Grant is an Assistant Professor of Medicine and Pediatrics at the Johns Hopkins University School of Medicine, and her primary research interest is in urban exposures and lung function growth.
Mayer A. Green Allergy Foundation Memorial Lecture: The Promise and Limits of Food Allergen Immunotherapy
|
Recognizing Health Disparities in Food Allergy
|
Carla Davis, MD
Dr. Davis is the Director of the Immunology, Allergy, and Retrovirology Division of the Department of Pediatrics at Baylor College of Medicine. She received her medical degree from Duke University and completed her residency program in pediatrics at Baylor College of Medicine in Houston, Texas. She completed her allergy and immunology fellowship at Baylor College of Medicine. After spending time in private practice, she joined the Baylor faculty and was appointed as a Professor in the Department of Pediatrics and Pathology, Immunology, Allergy, and Retrovirology Division in 2020. Dr. Davis is focused on improving the quality of life for infants, children, and adolescents with food allergies. She is dedicated to providing patients and their families with unparalleled, personalized, family-centered care. She is ultimately dedicated to finding causes and cures for food allergies and food allergy-related diseases.
Dr. Davis is the Director of the Texas Children's Hospital Food Allergy Program, which is involved in several NIH-funded clinical trials, including the SUNBEAM study evaluating the early predictors and mechanisms of food allergy and eczema, the PARK study evaluating omalizumab (anti-IgE) in preventing the atopic march and asthma, and the DEGAS study, a phase 2 randomized double-blind, placebo-controlled clinical trial to evaluate the efficacy of dupilumab in subjects with eosinophilic gastritis. Dr. Davis has a focus in the underlying food allergy mechanism of disease, most recently publishing a peanut oral immunotherapy clinical trial using maximum dose challenges showing desensitization is lost rapidly within one month after dosing discontinuation in the JACI: In Practice. Dr. Davis served as the President of the Texas, Allergy, Asthma and Immunology Society and as the Chair of the Diversity and a member of the Board of Directors of the American Academy of Allergy, Asthma, and Immunology. She is passionate about increasing diversity and equity in clinical care and research for patients with allergic and immunologic diseases.
Dr. Davis is the Director of the Immunology, Allergy, and Retrovirology Division of the Department of Pediatrics at Baylor College of Medicine. She received her medical degree from Duke University and completed her residency program in pediatrics at Baylor College of Medicine in Houston, Texas. She completed her allergy and immunology fellowship at Baylor College of Medicine. After spending time in private practice, she joined the Baylor faculty and was appointed as a Professor in the Department of Pediatrics and Pathology, Immunology, Allergy, and Retrovirology Division in 2020. Dr. Davis is focused on improving the quality of life for infants, children, and adolescents with food allergies. She is dedicated to providing patients and their families with unparalleled, personalized, family-centered care. She is ultimately dedicated to finding causes and cures for food allergies and food allergy-related diseases.
Dr. Davis is the Director of the Texas Children's Hospital Food Allergy Program, which is involved in several NIH-funded clinical trials, including the SUNBEAM study evaluating the early predictors and mechanisms of food allergy and eczema, the PARK study evaluating omalizumab (anti-IgE) in preventing the atopic march and asthma, and the DEGAS study, a phase 2 randomized double-blind, placebo-controlled clinical trial to evaluate the efficacy of dupilumab in subjects with eosinophilic gastritis. Dr. Davis has a focus in the underlying food allergy mechanism of disease, most recently publishing a peanut oral immunotherapy clinical trial using maximum dose challenges showing desensitization is lost rapidly within one month after dosing discontinuation in the JACI: In Practice. Dr. Davis served as the President of the Texas, Allergy, Asthma and Immunology Society and as the Chair of the Diversity and a member of the Board of Directors of the American Academy of Allergy, Asthma, and Immunology. She is passionate about increasing diversity and equity in clinical care and research for patients with allergic and immunologic diseases.
Operationalizing and Allergy Framework for COVID 19 Vaccinations
|
Quality/Safety in the Allergy Practice
|
Paige Wickner, MD, MPH
Paige Wickner, MD, MPH is a practicing allergist and immunologist in the Division of Allergy and Clinical Immunology at Brigham and Women’s Hospital (BWH) and an Assistant Professor of Medicine at Harvard Medical School. In addition, she is Vice President of Enterprise Patient Safety at CVS Health. Her focus is leading and partnering to deliver safe, high quality patient care. She has served as head of the Division of Allergy and Clinical Immunology Quality and Safety, and a medical director in the BWH Department of Quality and Safety leading the patient experience for the hospital. Dr. Wickner has innovated, operationalized and published on quality improvement and safety related to drug allergies, antibiotic stewardship and COVID-19 vaccination.
She graduated from Yale University and earned her medical degree from Dartmouth Medical School. She completed her internal medicine residency and allergy and immunology fellowship at Yale New Haven Hospital, and earned a masters of public health from Johns Hopkins Bloomberg School for Public Health.
Paige Wickner, MD, MPH is a practicing allergist and immunologist in the Division of Allergy and Clinical Immunology at Brigham and Women’s Hospital (BWH) and an Assistant Professor of Medicine at Harvard Medical School. In addition, she is Vice President of Enterprise Patient Safety at CVS Health. Her focus is leading and partnering to deliver safe, high quality patient care. She has served as head of the Division of Allergy and Clinical Immunology Quality and Safety, and a medical director in the BWH Department of Quality and Safety leading the patient experience for the hospital. Dr. Wickner has innovated, operationalized and published on quality improvement and safety related to drug allergies, antibiotic stewardship and COVID-19 vaccination.
She graduated from Yale University and earned her medical degree from Dartmouth Medical School. She completed her internal medicine residency and allergy and immunology fellowship at Yale New Haven Hospital, and earned a masters of public health from Johns Hopkins Bloomberg School for Public Health.
AERD – Diagnosis and Treatment
|
Workshop: Aspirin and NSAID Challenges
|
Tanya Laidlaw, MD
Tanya M. Laidlaw, MD is an Associate Professor of Medicine at Harvard Medical School in Boston, MA, in the Division of Allergy and Clinical Immunology at Brigham and Women’s Hospital (BWH) in Boston, where she is director of the Aspirin-Exacerbated Respiratory Disease (AERD) Center and Chief of the Section of Clinical and Translational Sciences.
Dr. Laidlaw earned her medical degree from the University of Massachusetts Medical School in Worcester. She then completed a residency in pediatrics at Massachusetts General Hospital in Boston and completed an allergy/immunology fellowship at BWH in 2006.
Dr Laidlaw’s initial research training was focused on the pathogenesis of asthma, of chronic rhinosinusitis with nasal polyps, and of AERD, particularly the pro-inflammatory role of mast cells, platelets, and specific lipids. Her research continues to be focused on understanding AERD and nasal polyposis, and she is dedicated to investigating the causative mechanisms and exploring new treatments. Her group at the AERD Center follows over 2300 patients with AERD who have nasal polyps and severe asthma, and she is involved in multiple ongoing research studies that are recruiting and enrolling patients. Her research findings have appeared in such publications as The England Journal of Medicine, the Journal of Allergy and Clinical Immunology: In Practice, and the Annals of Allergy, Asthma & Immunology.
A fellow of the American Academy of Allergy, Asthma & Immunology, Dr Laidlaw has served as chair or cochair of several of its committees. Other memberships include the American College of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology. She also assumed the role of Deputy Director of the Allergy and Asthma Assessment Group at the Immune Tolerance Network at the National Institute of Allergy and Infectious Diseases (NIAID) at the NIH.
Tanya M. Laidlaw, MD is an Associate Professor of Medicine at Harvard Medical School in Boston, MA, in the Division of Allergy and Clinical Immunology at Brigham and Women’s Hospital (BWH) in Boston, where she is director of the Aspirin-Exacerbated Respiratory Disease (AERD) Center and Chief of the Section of Clinical and Translational Sciences.
Dr. Laidlaw earned her medical degree from the University of Massachusetts Medical School in Worcester. She then completed a residency in pediatrics at Massachusetts General Hospital in Boston and completed an allergy/immunology fellowship at BWH in 2006.
Dr Laidlaw’s initial research training was focused on the pathogenesis of asthma, of chronic rhinosinusitis with nasal polyps, and of AERD, particularly the pro-inflammatory role of mast cells, platelets, and specific lipids. Her research continues to be focused on understanding AERD and nasal polyposis, and she is dedicated to investigating the causative mechanisms and exploring new treatments. Her group at the AERD Center follows over 2300 patients with AERD who have nasal polyps and severe asthma, and she is involved in multiple ongoing research studies that are recruiting and enrolling patients. Her research findings have appeared in such publications as The England Journal of Medicine, the Journal of Allergy and Clinical Immunology: In Practice, and the Annals of Allergy, Asthma & Immunology.
A fellow of the American Academy of Allergy, Asthma & Immunology, Dr Laidlaw has served as chair or cochair of several of its committees. Other memberships include the American College of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology. She also assumed the role of Deputy Director of the Allergy and Asthma Assessment Group at the Immune Tolerance Network at the National Institute of Allergy and Infectious Diseases (NIAID) at the NIH.
Patient Education in the Office
|
Oral Food Challenges in Infants and Toddlers
|
David Stukus, MD
David Stukus is a Professor of Clinical Pediatrics in the Division of Allergy/Immunology at Nationwide Children's Hospital and The Ohio State University College of Medicine. At his institution, he serves as the Director of the Food Allergy Treatment Center and Associate Director of the Pediatric Allergy/Immunology Fellowship Training Program. Dr. Stukus is a member of the Board of Regents for the American College of Allergy, Asthma and Immunology, the Social Media Editor and host of the podcast series for the American Academy of Allergy, Asthma and Immunology, and is one of twelve invited members for the Joint Task Force for Practice Parameters for Allergy/Immunology. Dr. Stukus has published two textbooks and over 70 peer reviewed manuscripts. You can find him on Twitter and Instagram @AllergyKidsDoc, where he has amassed over 40,000 followers.
David Stukus is a Professor of Clinical Pediatrics in the Division of Allergy/Immunology at Nationwide Children's Hospital and The Ohio State University College of Medicine. At his institution, he serves as the Director of the Food Allergy Treatment Center and Associate Director of the Pediatric Allergy/Immunology Fellowship Training Program. Dr. Stukus is a member of the Board of Regents for the American College of Allergy, Asthma and Immunology, the Social Media Editor and host of the podcast series for the American Academy of Allergy, Asthma and Immunology, and is one of twelve invited members for the Joint Task Force for Practice Parameters for Allergy/Immunology. Dr. Stukus has published two textbooks and over 70 peer reviewed manuscripts. You can find him on Twitter and Instagram @AllergyKidsDoc, where he has amassed over 40,000 followers.
Rheumatology in the AI Clinic
|
Immune Dysregulation
|
Meghan Cooper, MD
Dr. Cooper is an Associate Professor of Pediatrics at Washington University in St. Louis and Director of Clinical Immunology and the Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies at St. Louis Children’s Hospital. She cares for patients in Pediatric Rheumatology and Immunology clinics, with a clinical interest in immune dysregulation. Dr. Cooper’s laboratory focuses on basic mechanisms of immune cell activation and regulation. She investigates defects of the immune system that lead to pediatric autoimmunity and immune deficiency, using genetic sequencing to uncover novel molecular mechanisms of pediatric disease. Her laboratory also studies mechanisms of NK cell activation, including long-term priming of NK cells for memory functions. Dr. Cooper has an interest in education of physician-scientists and serves as an Associate Program Director for the MSTP program at Washington University.
Dr. Cooper is an Associate Professor of Pediatrics at Washington University in St. Louis and Director of Clinical Immunology and the Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies at St. Louis Children’s Hospital. She cares for patients in Pediatric Rheumatology and Immunology clinics, with a clinical interest in immune dysregulation. Dr. Cooper’s laboratory focuses on basic mechanisms of immune cell activation and regulation. She investigates defects of the immune system that lead to pediatric autoimmunity and immune deficiency, using genetic sequencing to uncover novel molecular mechanisms of pediatric disease. Her laboratory also studies mechanisms of NK cell activation, including long-term priming of NK cells for memory functions. Dr. Cooper has an interest in education of physician-scientists and serves as an Associate Program Director for the MSTP program at Washington University.
Resident Abstracts
|
|
Late-Onset X-Linked Chronic Granulomatous Disease: Identification of a Novel Variant in the CYBB Gene
Nemours Children’s Hospital/Thomas Jefferson University | Hannah Harrison, MD |
The Genetics of Eczema Herpeticum
St. Christopher’s Hospital for Children | Elisabeth Hodara, MD |
|
|
Clinical Outcomes of Bacterial Pneumonia in Patients with Penicillin Allergy Label
Penn State Health Milton S. Hershey Medical Center| Lauren Kaminsky, MD, PhD |
Cyclosporine for Omalizumab-Refractory Chronic Spontaneous Urticaria - A Report of Five Cases
University of Pennsylvania | Anthony LaCava, MD |
|
|
Racial and Ethnic Disparities with Allergen Immunotherapy in Patients with Allergic Rhinitis
Milton S. Hershey Medical Center, Penn State College of Medicine | Sunjay Modi, MD |
Baseline Characteristics of Patients who Fail Low-Dose Challenge and Patients who Reach Maintenance OIT to Cashew
Children’s Hospital of Philadelphia | Kim Nguyen, MD |
|
|
A Case of Cutaneous Botryomycosis in a Patient with X-linked Agammaglobulinemia
Penn State Health Milton S. Hershey Medical Center | Catherine Popadiuk, DO |
Asthma medication adherence during the COVID-19 pandemic in children at high risk of exacerbation
Children’s Hospital of Philadelphia | Colleen Shannon, MD, MPH |
To Claim CME for the Above Sessions
To obtain a CME certificate for the 2022 PAAA Annual Meeting Enduring Materials, please use the link provided below to view and complete the online post-course survey which is available through our learning management system. You will need to create a web account for the PAMED website if you don’t already have one. Membership in PAMED is not required for a Web account. The information required to create a web account includes first and last names, date of birth, and an email address (cannot be a shared email address—each learner profile must have a distinct email address of record). Entering your license number is optional but is helpful in establishing your learner profile.
Once you have created your account/logged in, you will be redirected to the course and able to view and complete the survey. A CME certificate will be available to download, print, or email after you have completed the survey. Please note that you cannot use Internet Explorer to access our learning management system as it is not supported by the platform. You must use Chrome or another browser.
Once you have created your account/logged in, you will be redirected to the course and able to view and complete the survey. A CME certificate will be available to download, print, or email after you have completed the survey. Please note that you cannot use Internet Explorer to access our learning management system as it is not supported by the platform. You must use Chrome or another browser.
If you have any questions about the process to claim CME, please feel free to contact the CME office at [email protected]. If you need assistance creating a website account, please contact our Knowledge Center at 855-PAMED4U (855-726-3348) or [email protected].